Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 269, Issue 2, pp 571–577 | Cite as

Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat

  • Sigrun ChrubasikEmail author
  • Beate Beime
  • Florella Magora
Laryngology

Abstract

Benzocaine lozenges are popular in symptomatic treatment of acute sore throat. The aim of this study was to evaluate if sucking a benzocaine lozenge was superior to a placebo lozenge in patients with pain while swallowing. Volunteers with acute, uncomplicated sore throat received randomly and double-blind either a benzocaine 8 mg or a placebo lozenge. Pain was assessed on a numerical visual rating scale. The primary outcome measure was the sum of the pain intensity differences (SPID) over 2 h. Secondary outcome measures included the number of patients who reported 50% or more of their baseline pain score (responders) and those with worthwhile and complete pain relief, the times to worthwhile/complete pain relief and to pain recurrence and the occurrence of any adverse effects. A predefined interim analysis after including 50 patients revealed the superiority of benzocaine versus placebo in the SPID (p = 0.0086). At this time, a total of 165 patients had been recruited (full analysis set, FAS) and underwent statistical analysis. In the FAS, median SPID had significantly more decreased in patients receiving benzocaine compared to placebo (−12 vs. − 5, p = 0.001). There were significantly more responders and patients with worthwhile pain relief in group benzocaine. The number of patients with complete pain relief was very small. Median time to worthwhile pain relief was 20 min (benzocaine) and >45 min (placebo). Adverse events were not observed. Benzocaine lozenges are superior to placebo lozenges and a useful, well-tolerated treatment option to reduce painful pharyngeal discomfort.

Keywords

Benzocaine Local anaesthetic Placebo Clinical trial Sore throat AnästhesinR 

Notes

Acknowledgments

The study was funded by Dr. Ritsert Pharma, Klausenweg 21, D-69412 Eberbach.

Conflict of interest

None of the other authors had any conflict of interest.

References

  1. 1.
    Ayres JW, Lorskulsint D, Lock A (1975) Absorption of 3H-benzocaine from ointments following rectal administration in rats. J Pharm Sci 64:1958–1960PubMedCrossRefGoogle Scholar
  2. 2.
    Adriani J, Zepernick R (1964) Clinical effectiveness of drugs used for topical anesthesia. JAMA 188:711–716PubMedCrossRefGoogle Scholar
  3. 3.
    Weinstein S (1977) Effects of local anesthetics on tactile sensitivity thresholds for cutaneous and mucous membranes. J Invest Dermatol 69:136–145PubMedCrossRefGoogle Scholar
  4. 4.
    Roghani S, Duperon DF, Barcohana N (1999) Evaluating the efficacy of commonly used topical anesthetics. Pediatr Dent 21:197–200PubMedGoogle Scholar
  5. 5.
    Hollmann MW, Gross A, Jelacin N, Durieux ME (2001) Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology 95:113–122PubMedCrossRefGoogle Scholar
  6. 6.
    Morrow ME, Berry CW (1988) Antimicrobial properties of topical anesthetic liquids containing lidocaine or benzocaine. Anesth Prog 35:9–13PubMedGoogle Scholar
  7. 7.
  8. 8.
    Kagan G, Huddlestone L, Wolstencroft P (1982) Two lozenges containing benzocaine assessed in the relief of sore throat. J Int Med Res 10:443–446PubMedGoogle Scholar
  9. 9.
    Busch R, Graubaum HJ, Grünwald J, Schmidt M (2010) Double-blind comparison of two types of benzocaine lozenges for the treatment of acute pharyngitis. Arzneimittelforschung 60:245–248PubMedCrossRefGoogle Scholar
  10. 10.
    Bauer P, Köhne K (1994) Evaluation of experiments with adaptive interim analyses. Biometrics 50:1029–1041Google Scholar
  11. 11.
    Wonnemann M, Helm I, Stauss-Grabo M, Röttger-Luer P, Tran CT, Canenbley R, Donath F, Nowak H, Schug BS, Blume HH (2007) Lidocaine 8 mg sore throat lozenges in the treatment of acute pharyngitis. A new therapeutic option investigated in comparison to placebo treatment. Arzneimittelforschung 57:689–697PubMedGoogle Scholar
  12. 12.
    de Mey C, Peil H, Kölsch S, Bubeck J, Vix JM (2008) Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation. Arzneimittelforschung 58:557–568PubMedGoogle Scholar
  13. 13.
    Malerba M, Ragnoli B (2008) Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol 4:1119–1129PubMedCrossRefGoogle Scholar
  14. 14.
    Beeh KM, Beier J, Esperester A, Paul LD (2008) Antiinflammatory properties of ambroxol. Eur J Med Res 13:557–562PubMedGoogle Scholar
  15. 15.
    Buchholz V, Leuwer M, Ahrens J, Foadi N, Krampfl K, Haeseler G (2009) Topical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like manner. Naunyn Schmiedebergs Arch Pharmacol 380:161–168PubMedCrossRefGoogle Scholar
  16. 16.
    Thomas MJ (2010) ACP Journal Club. Amylmetacresol and 2, 4-dichlorobenzyl alcohol lozenges were better than placebo lozenges for relief of acute sore throat. Ann Intern Med 153:JC2–JC6PubMedGoogle Scholar
  17. 17.
    Bienen H, Raus I (1981) Therapeutic comparison of throat lozenges (author’s transl). MMW Munch Med Wochenschr 123:745–747PubMedGoogle Scholar
  18. 18.
    Raus I (1976) Clinical studies on Frubienzyme in a controlled double-blind trial. Fortschr Med 94:1579–1582PubMedGoogle Scholar
  19. 19.
    Watson N, Nimmo WS, Christian J, Charlesworth A, Speight J, Miller K (2000) Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety. Int J Clin Pract 54:490–496PubMedGoogle Scholar
  20. 20.
    Blagden M, Christian J, Miller K, Charlesworth A (2002) Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres. Int J Clin Pract 56:95–100PubMedGoogle Scholar
  21. 21.
    Kapila YV, Dodds WJ, Helm JF, Hogan WJ (1984) Relationship between swallow rate and salivary flow. Dig Dis Sci 29:528–533PubMedCrossRefGoogle Scholar
  22. 22.
    García Rodríguez LA, Hernández-Díaz S (2001) Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 12:570–576PubMedCrossRefGoogle Scholar
  23. 23.
    Nguyen ST, Cabrales RE, Bashour CA, Rosenberger TE Jr, Michener JA, Yared JP, Starr NJ (2000) Benzocaine-induced methemoglobinemia. Anesth Analg 90:369–371PubMedGoogle Scholar
  24. 24.
    Hegedus F, Herb K (2005) Benzocaine-induced methemoglobinemia. Anesth Prog 52:136–139PubMedCrossRefGoogle Scholar
  25. 25.
    Dahshan A, Donovan GK (2006) Severe methemoglobinemia complicating topical benzocaine use during endoscopy in a toddler: a case report and review of the literature. Pediatrics 117:e806–e809PubMedCrossRefGoogle Scholar
  26. 26.
    Throm MJ, Stevens MD, Hansen C (2007) Benzocaine-induced methemoglobinemia in two patients: interdisciplinary collaboration, management, and near misses. Pharmacotherapy 27:1206–1214PubMedCrossRefGoogle Scholar
  27. 27.
    Bourke DL, Marcucci C (2010) Banana blues. Anesth Analg 110:259–260PubMedCrossRefGoogle Scholar
  28. 28.
    Guay J (2009) Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg 108:837–845PubMedCrossRefGoogle Scholar
  29. 29.
    Weinberg GL (2009) Banning benzocaine: of bananas, bureaucrats, and blue men. Anesth Analg 108:699–701PubMedCrossRefGoogle Scholar
  30. 30.
  31. 31.
  32. 32.
    Moore TJ, Walsh CS, Cohen MR (2004) Reported adverse event cases of methemoglobinemia associated with benzocaine products. Arch Intern Med 64:1192–1196CrossRefGoogle Scholar
  33. 33.
    Chan TV (2010) The patient with sore throat. Med Clin North Am 94:923–943PubMedCrossRefGoogle Scholar
  34. 34.
    Robertson KA, Volmink JA, Mayosi BM (2005) Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 5:11PubMedCrossRefGoogle Scholar
  35. 35.
    Centor RM (2009) Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern Med 151:812–815PubMedGoogle Scholar
  36. 36.
    Ohlsson A, Clark K (2004) Antibiotics for sore throat to prevent rheumatic fever: yes or no? How the Cochrane Library can help. CMAJ 171:721–723PubMedCrossRefGoogle Scholar
  37. 37.
    Matthys J, De Meyere M, van Driel ML, De Sutter A (2007) Differences among international pharyngitis guidelines: not just academic. Ann Fam Med 5:436–443PubMedCrossRefGoogle Scholar
  38. 38.
    Spurling GK, Del Mar CB, Dooley L, Foxlee R (2007) Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev (3):CD004417Google Scholar
  39. 39.
    Arnold SR, Straus SE (2005) Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev (4):CD003539Google Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Sigrun Chrubasik
    • 1
    Email author
  • Beate Beime
    • 2
  • Florella Magora
    • 3
  1. 1.Institute of Forensic MedicineUniversity of FreiburgFreiburgGermany
  2. 2.Diapharm OldenburgOldenburgGermany
  3. 3.Department of Anaesthesia and Intensive CareHebrew UniversityJerusalemIsrael

Personalised recommendations